These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11220011)

  • 1. The kidney in hypertension.
    Wright JR; Kalra PA
    Practitioner; 2001 Jan; 245(1618):41-6. PubMed ID: 11220011
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antihypertensive treatment in kidney diseases: whom, with what, how intensively?].
    Ritz E; Heidland A; Nowack R; Rambausek M
    Dtsch Med Wochenschr; 1990 Aug; 115(35):1325-8. PubMed ID: 2202580
    [No Abstract]   [Full Text] [Related]  

  • 3. [Calcium antagonist treatment of renal hypertension--a new step on the way to optimizing hypotensive therapy].
    Galstian GM
    Ter Arkh; 1989; 61(8):138-43. PubMed ID: 2686067
    [No Abstract]   [Full Text] [Related]  

  • 4. The kidney in essential hypertension.
    Losito A
    Compr Ther; 1989 Aug; 15(8):19-26. PubMed ID: 2670406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of hypotensive therapy on kidney function in hypertensive states].
    Shershnev VG; Shcherban' NN; Gorodetskiĭ AL
    Ter Arkh; 1973 Oct; 45(10):85-8. PubMed ID: 4783250
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of renoparenchymal hypertension in chronic glomerulonephritis with normal and impaired renal function].
    Stefanov G; Tishkov I; Todorova L
    Vutr Boles; 1982; 21(5):49-53. PubMed ID: 7164406
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment problems of nephrogenic arterial hypertension].
    Abrarova ER; Kosorukova NN
    Ter Arkh; 1996; 68(6):77-82. PubMed ID: 8771695
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nephroangiosclerosis or hypertensive nephropathy].
    del Río Vázquez A
    Rev Clin Esp; 1994 Aug; 194(8):620-2. PubMed ID: 7938843
    [No Abstract]   [Full Text] [Related]  

  • 9. Minoxidil use in proteinuric renal disease.
    Diskin CJ
    Acta Med Croatica; 2008 Feb; 62(1):93. PubMed ID: 18365509
    [No Abstract]   [Full Text] [Related]  

  • 10. Overview: mechanisms of hypertension: cells, hormones, and the kidney.
    August P
    J Am Soc Nephrol; 2004 Aug; 15(8):1971-3. PubMed ID: 15284282
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypertension of renal origin.
    Acchiardo S
    Medicina (B Aires); 1979; 39 Suppl 1():66-70. PubMed ID: 550046
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of hypertension on function of the transplanted kidney--3 years follow-up].
    Oko A; Olejnik A; Idasiak-Piechocka I; Włodarczyk Z; Głyda M; Czekalski S
    Przegl Lek; 2003; 60(11):686-9. PubMed ID: 15058033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary and secondary (renovascular) arterial hypertension].
    Hausberg M; Krämer BK
    Dtsch Med Wochenschr; 2011 Jun; 136(22):1187-90. PubMed ID: 21611926
    [No Abstract]   [Full Text] [Related]  

  • 14. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of the mechanism of action of a vasodepressor lipid of renal origin and its relation to the antihypertensive function of the kidneys].
    Somova LI
    Patol Fiziol Eksp Ter; 1973; 17(1):17-22. PubMed ID: 4755538
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of antihypertensive agents on intrarenal hemodynamics].
    Guedon J
    Presse Med; 1988 Oct; 17(34):1729-31. PubMed ID: 2978304
    [No Abstract]   [Full Text] [Related]  

  • 17. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glomerular-capillary hypertension. Experimental findings and their clinical importance].
    Anderson S; Brenner BM
    Dtsch Med Wochenschr; 1988 Oct; 113(40):1543-5. PubMed ID: 3048961
    [No Abstract]   [Full Text] [Related]  

  • 19. Control of high blood pressure in primary health care.
    Banegas JR
    Am J Hypertens; 2006 Feb; 19(2):146. PubMed ID: 16448883
    [No Abstract]   [Full Text] [Related]  

  • 20. Can we really lessen kidney damage to the point that the loss of renal function of progressive nephropathy may revert?
    Abbate M; Remuzzi G
    J Am Soc Nephrol; 2003 May; 14(5):1411-4. PubMed ID: 12707411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.